Evidence map›Paper›PMID 26295461›Full record

ReviewCurrent medicinal chemistry2015

Sesterterpenoids with Anticancer Activity.

Antonio Evidente, Alexander Kornienko, Florence Lefranc, Alessio Cimmino, Ramesh Dasari, Marco Evidente, Véronique Mathieu, Robert Kiss

Open access · greenAbstract readReview
In one paragraph

Review in Current medicinal chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Terpenes in the management of chronic kidney disease.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  8. Review
  9. Review
  10. Article
  11. The power of heteronemin in cancers.Journal of biomedical science · 2022
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Antibacterial scalarane fromBeilstein journal of organic chemistry · 2020
    Article
  17. Functional Gene Network of Prenyltransferases inMolecules (Basel, Switzerland) · 2019
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Antonio EvidenteDipartimento di Scienze Chimiche, Università di Napoli Federico II, Complesso Universitario Monte S. Angelo, Via Cintia 4, 80126 Napoli, Italy. evidente@unina.it.
Alexander Kornienko
Florence Lefranc
Alessio Cimmino
Ramesh Dasari
Marco Evidente
Véronique Mathieu
Robert Kiss
Université Libre de Bruxelles · BE

Funding

Mode of Action of the Amaryllidaceae Alkaloid Lycorine-Promising Anticancer AgentR15CA186046 · NCI · TEXAS STATE UNIVERSITY · PI KORNIENKO, ALEXANDER · 2014 to 2014
$476k
NCI NIH HHS 1R15-CA186046-01A1NCI NIH HHS R15 CA186046
6 · The paper itself

Abstract

Terpenes have received a great deal of attention in the scientific literature due to complex, synthetically challenging structures and diverse biological activities associated with this class of natural products. Based on the number of C5 isoprene units they are generated from, terpenes are classified as hemi- (C5), mono- (C10), sesqui- (C15), di- (C20), sester- (C25), tri (C30), and tetraterpenes (C40). Among these, sesterterpenes and their derivatives known as sesterterpenoids, are ubiquitous secondary metabolites in fungi, marine organisms, and plants. Their structural diversity encompasses carbotricyclic ophiobolanes, polycyclic anthracenones, polycyclic furan-2-ones, polycyclic hydroquinones, among many other carbon skeletons. Furthermore, many of them possess promising biological activities including cytotoxicity and the associated potential as anticancer agents. This review discusses the natural sources that produce sesterterpenoids, provides sesterterpenoid names and their chemical structures, biological properties with the focus on anticancer activities and literature references associated with these metabolites. A critical summary of the potential of various sesterterpenoids as anticancer agents concludes the review.

Indexed as

Antineoplastic AgentsAquatic OrganismsBiological ProductsCell SurvivalFungiHumansPlantsSesterterpenesAntineoplastic AgentsBiological ProductsSesterterpenes

Identifiers

PMID26295461
PMCPMC4955362
OpenAlexW2275771791

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.